Blue Harbour Group’s Pediatrix Medical MD Stock Holding History

Blue Harbour Group’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,383,000	Closed	-$37.6M	–	16
2019 Q1	$37.6M	Sell	1,383,000 -3,220,916	-70%	-$108M	2.2%	11
2018 Q4	$152M	Buy	4,603,916 +450,000	+11%	+$18.1M	8.1%	6
2018 Q3	$194M	Hold	4,153,916	–	–	8.96%	6
2018 Q2	$180M	Sell	4,153,916 -354,952	-8%	-$17M	7.28%	7
2018 Q1	$251M	Buy	4,508,868 +397,600	+10%	+$21.8M	8.71%	6
2017 Q4	$220M	Buy	4,111,268 +1,592,589	+63%	+$75.1M	7.8%	5
2017 Q3	$109M	Buy	2,518,679 +982,600	+64%	+$46.7M	3.92%	10
2017 Q2	$92.7M	Hold	1,536,079	–	–	3.57%	13
2017 Q1	$107M	Sell	1,536,079 -73,089	-5%	-$5.08M	3.84%	12
2016 Q4	$107M	Buy	1,609,168 +1,064,632	+196%	+$69.3M	3.59%	9
2016 Q3	$36.1M	Buy	+544,536	New	+$37.2M	1.33%	12

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Blue Harbour Group's MD Position: Q2 2019 in Review

Blue Harbour Group sold out of Pediatrix Medical (MD) in Q2 2019, closing a stake of 1,383,000 shares — an estimated $37.6M sold.

Blue Harbour Group first reported a position in MD in Q3 2016 and held it in 11 quarters. The position peaked at $251M in Q1 2018. 247 funds tracked by Wall St. Rank hold MD as of Q2 2019.

Blue Harbour Group reported no remaining Pediatrix Medical position as of Q2 2019 after selling out during the quarter.
Blue Harbour Group sold 1,383,000 Pediatrix Medical shares in Q2 2019, an estimated $37.6M.
Blue Harbour Group first reported a position in Pediatrix Medical in Q3 2016 and held it in 11 quarters.
Blue Harbour Group's Pediatrix Medical position peaked at $251M in Q1 2018.
247 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2019.

Based on Blue Harbour Group's 13F filing for Q2 2019, filed 14 Aug 2019.